hTERT RNA Detection Qualitative Test
Understanding the hTERT RNA Detection Test
The hTERT RNA Detection Qualitative Test represents a cutting-edge advancement in molecular diagnostics, specifically designed to detect the presence of human telomerase reverse transcriptase (hTERT) RNA. Telomerase, the enzyme responsible for maintaining telomere length, is reactivated in approximately 85-90% of human cancers, making hTERT expression a crucial biomarker for cancer detection and monitoring.
What Does This Test Measure?
This sophisticated diagnostic test specifically detects the qualitative presence of hTERT RNA using highly sensitive Real Time PCR technology. The test identifies:
- Presence or absence of hTERT RNA expression
- Telomerase activity at the molecular level
- Cellular immortalization markers
- Early indicators of malignant transformation
Who Should Consider This Test?
The hTERT RNA Detection Qualitative Test is recommended for individuals experiencing:
- Unexplained symptoms suggestive of cancer development
- Family history of cancer requiring enhanced screening
- Monitoring treatment response in diagnosed cancer patients
- Evaluation of suspicious lesions or abnormal growths
- Assessment of cancer recurrence risk
Clinical Applications
This test is particularly valuable for patients with concerns related to pancreatic cancer, hematological malignancies, and various solid tumors where telomerase activation plays a critical role in disease progression.
Key Benefits of hTERT RNA Detection
- Early Cancer Detection: Identifies molecular changes before clinical symptoms manifest
- Treatment Monitoring: Tracks treatment effectiveness through hTERT expression changes
- Personalized Care: Provides insights for tailored treatment approaches
- High Sensitivity: Detects minimal residual disease with exceptional accuracy
- Comprehensive Analysis: Evaluates multiple sample types for thorough assessment
Understanding Your Test Results
Positive Result Interpretation
A positive hTERT RNA detection indicates active telomerase expression, which may suggest:
- Presence of malignant cells
- Active cancer progression
- Need for further diagnostic evaluation
- Potential requirement for treatment intervention
Negative Result Interpretation
A negative result suggests absence of detectable hTERT RNA, which may indicate:
- No evidence of active telomerase expression
- Potential response to cancer treatment
- Lower likelihood of active malignancy
- Need for continued monitoring as recommended by your physician
Test Pricing Information
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $192 |
| Regular Price | $226 |
Sample Collection and Processing
Our test accepts multiple sample types to ensure comprehensive analysis:
- Bone marrow aspirations
- Pancreatic tissue samples
- Ex vivo Pancreatic Ducts Brushing
- Pancreatic Juice
- Urine samples
Turnaround Time
Results are typically available within:
- 36 hours via email
- 24 hours via phone consultation
- 3rd working day for comprehensive report delivery
Pre-Test Instructions
To ensure accurate results, please:
- Sign the required consent document
- Bring complete clinical history of the patient
- Follow specific sample collection guidelines
- Consult with our genetic specialists for personalized guidance
Nationwide Availability
GGC DNA has testing facilities across the United States, serving major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified laboratories ensures consistent, high-quality testing standards nationwide.
Take Control of Your Health Today
Early detection through advanced molecular testing can significantly impact cancer outcomes. The hTERT RNA Detection Qualitative Test provides crucial insights that can guide your healthcare journey. Our team of genetic specialists and oncologists are available to discuss your results and next steps.
Ready to schedule your test? Contact us today at +1(267) 388-9828 or book your appointment online. Take the first step toward comprehensive cancer screening and personalized care with GGC DNA.
